Archived News
2023
12/28/2023
CLIA Fees and Personnel Changes Published in Today's Federal Register
12/05/2023
NILA and AAB Comment on FDA's Proposed LDT Rule
11/15/2023
House Passes 1-Year Delay of PAMA Reimbursement Cuts
11/06/2023
NILA Urges Congress to Provide Immediate PAMA Relief
09/19/2023
NILA Shares Concerns with House Leaders Regarding "Lower Costs, More Transparency Act"
09/19/2023
NILA Urges OMB to Reconsider FDA's Proposed Rules Regulating LDTs
09/13/2023
CMS Announces NCCI Edits will be Rescinded
09/07/2023
NILA Urges CMS to Withdraw NCCI Edit for Presumptive and Definitive Drug Tests
06/22/2023
NILA Comments on Interoperability Issues
05/22/2023
33 Healthcare Groups Sign Letter of Support for SALSA
04/27/2023
VALID Act Re-Introduced in House of Representatives
03/28/2023
SALSA introduced in the 118th Congress
03/27/2023
NILA Releases Statement on Reauthorization of the Pandemics and All Hazards Preparedness Act (PAHPA)
03/22/2023
SALSA to be Reintroduced Soon
03/02/2023
COVID-19 Public Health Emergency to End May 11, 2023
02/06/2023
SALSA Reintroduction in the Works
2022
12/09/2022
NILA Urges House/Senate Leaders to Exclude VALID Act from Year-end Legislation
12/08/2022
MPox (formerly Monkeypox) Public Health Emergency to End on January 31, 2023
07/06/2022
CMS Proposes New Rule for Rural Emergency Hospitals (REHs) and Critical Access Hospitals (CAHs)
06/22/2022
NILA Applauds Introduction of the Saving Access to Lab Services Act
06/14/2022
Lab Update: CDC Biosafety Town Hall on Medical Device Design - June 24
06/13/2022
FDA Authorizes First COVID-19 Test to Identify Specific SARS-CoV-2 Lineages
06/13/2022
Lab Advisory: CDC Publishes Monkeypox Virus PCR Testing Procedure
05/23/2022
NILA one of nine parties to new CDC Memorandum of Understanding
05/23/2022
NILA Comments on Discussion Draft of VALID Act released May 17, 2022
03/17/2022
HRSA Program for COVID-19 Testing for the Uninsured
03/04/2022
Announcing the 2022 NILA Lab Leaders Forum and Mid-Year Meeting
02/24/2022
FDA Update - Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers
02/04/2022
NILA Submits Comments on the PREVENT Pandemics Act Discussion Draft
2021
12/7/2021
Congress Reaches Deal to Delay PAMA Cuts, Data Reporting
12/2/2021
Two Court Injunctions Halt CMS Vaccine Mandate for Healthcare Workers Nationwide
11/30/2021
NILA, Partners ask Congress to Stop Harmful Payment Cuts to Clinical Laboratories
10/29/2021
Lab Advisory: CDC Updates Blood Lead Reference Value
9/20/2021
PAMA Recommendations Delivered to Capitol Hill
8/23/2021
NILA Comments on the VALID Act of 2021 (H.R.4128/S.2209)
7/16/2021
NILA Comments on Lab Provisions in Draft of CURES Act 2.0
6/24/2021
NILA Statement on the VALID Act
6/11/2021
NILA Writes Letter to Secretary Becerra Regarding Federal Oversight of LDTs
5/14/2021
NILA Letter to MedPAC Regarding PAMA Fee Schedule Calculations
4/29/2021
NILA, AAB and Partners Request $60M for Advanced Molecular Detection (AMD) Program
1/15/2021
NILA Supports President-Elect Biden’s Plans to Expand and Improve COVID-19 Testing Supplies
2020
12/21/2020
NILA Comments on CMS Rules for Posting COVID-19 Pricing Data
12/2/2020
Lab Group Letter to Biden Transition Team regarding COVID-19 Supply Shortage
11/21/2020
FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
11/20/2020
FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccine Candidate
11/19/2020
FDA Authorizes Drug Combination for Treatment of COVID-19
11/18/2020
Waste Management Guidance for SARS-CoV-2 Point-of-Care Testing
11/17/2020
NILA’s Letter to CMS Regarding Changes to Reimbursement for COVID-19 Diagnostic Tests
CDC Releases 6th Edition of Biosafety in Microbiology and Biomedical Laboratories
11/16/2020
FDA Update on FAQs on Testing for SARS-CoV-2
11/13/2020
CDC Updates FAQs to Include Information on Cycle Threshold Value
11/12/2020
CMS IQCP Clarification for EUA Tests
11/11/2020
CMS Takes Steps to Ensure Medicare Beneficiaries Have Wide Access to COVID-19 Antibody Treatment
11/3/2020
CDC Updates Specimen Collection Guidelines for COVID-19
11/2/2020
NILA’s Comment Letter Regarding the Interim Final Rule on COVID-19 Test Result Reporting
10/26/2020
Upcoming CLIAC Meeting on October 28-29, 2020
10/19/2020
NILA Questions FDA Decision to Suspend EUAs for COVID-19 LDTs
10/15/2020
CMS Changes Medicare Payment to Support Faster COVID-19 Diagnostic Testing
CDC Publishes New Web Page on Point-of-Care Testing for COVID-19
10/5/2020
NILA Members Report Continued Supply Shortages, Potential Increased COVID-19 Testing Capacity
10/2/2020
FDA Updates the SARS-CoV-2 Reference Panel Comparative Data
10/1/2020
CSTE Posts New Electronic Laboratory Reporting Points of Contact for COVID-19
9/24/2020
NILA's September 18 Letter to MedPAC Regarding MedPAC's Review of PAMA (PDF)
9/23/2020
Lab Advisory: LOINC In-Vitro Diagnostic (LIVD) Codes for SARS-CoV-2 Antigen Tests
9/22/2020
CDC, APHL and CSTE Standardized ELR Flat File
9/18/2020
CDC Updates Guidance on Testing for SARS-CoV-2
9/9/2020
U.S. FDA Update - FAQs on Testing for SARS-CoV-2
9/3/2020
CMS Issues New Surveyor Guidance for SARS-CoV-2 Laboratory Test Result Reporting
8/31/2020
Join the Next Clinical Laboratory COVID-19 Response Call Today, August 31 at 3:00 PM EDT
8/29/2020
CMS Publishes New CLIA FAQs
8/26/2020
CMS Issues New Rule for SARS-CoV-2 Laboratory Test Result Reporting
8/24/2020
FDA FAQ Update: New Information on Testing for SARS-CoV-2
8/18/2020
NILA Applauds CRL for Launching Saliva-Based COVID-19 Test
8/16/2020
CDC LOCS Lab Advisory: New COVID-19 Antigen Testing Guidance
CDC LOCS Lab Update: FDA Updates FAQs about Testing for SARS-CoV-2
8/13/2020
Joint Commission Revising Several Laboratory Accreditation Requirements
8/10/2020
CDC Responds to NILA Request that Record Reporting Requirements for COVID-19 Tests be Reconsidered
8/5/2020
CDC Updates Reporting FAQs for COVID-19 Testing
7/31/2020
Update on COVID-19 Laboratory Reporting Requirements
HEALS Act Introduced - Read NILA's Summary
7/28/2020
FDA Issues COVID-19 Testing and Policy Updates
CMS Updates Data on COVID-19 Impacts on Medicare Beneficiaries
7/24/2020
CDC Releases New Test Pooling Guidance for SARS-CoV-2
7/23/2020
CDC Publishes Primers and Probes for Research Use Only SARS-CoV-2 Multiplex Assay
CDC Releases New Test Pooling Guidance for SARS-CoV-2
7/22/2020
Update on Laboratory Reporting Guidance for SARS-CoV-2
7/18/2020
FDA Amends Instructions for Use of CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel
7/16/2020
NILA Letter to HHS Secretary Azar Requests Delay in Implementation of Lab Data Reporting Guidance
FDA Releases New Information on Testing for SARS-CoV-2
7/11/2020
CDC Publishes New General Laboratory Safety Guidance
7/10/2020
Laboratory Stakeholders Ask Administration to Improve Access to Testing Supplies
7/9/2020
CDC Multiplex Assay Receives Authorization from FDA
7/8/2020
Letter to VP Pence from NILA and other organizations addressing demand for COVID-19 testing supplies
7/7/2020
FDA Letter Warns of False Positive Results with BD SARS-CoV-2 Reagents for the BD Max System
7/6/2020
NILA’s Comments on Palmettos LCD for Toxicology
7/1/2020
DOT Issues Safety Notice for Transportation of COVID-19 Diagnostic Samples
Burkholderia pseudomallei in Southwestern United States
6/29/2020
FDA and CMS Update on Pooling for Diagnostic and Surveillance Testing for SARS-CoV-2
6/26/2020
NILA Letter to Senator Alexander Regarding Future Pandemics
6/20/2020
FDA Updates Website, Issues Warning Letters, and Revokes Chembio EUA
6/12/2020
CDC Updates Laboratory Biosafety Guidelines and Questions & Answers
6/10/2020
FDA Posts Information from Independent Evaluations of COVID-19 Serological Tests
6/6/2020
HHS Issues New CARES Act Guidance
6/1/2020
Lab Alert: Molecular Transport Media (MTM) and Cyanide Gas
5/27/2020
CDC Releases Interim Guidance for Coronavirus Disease (COVID-19) Antibody Testing
5/22/2020
FDA Removes Several COVID-19 Antibody Tests and Provides Additional Information
5/11/2020
CDC Weekly Call with Clinical Labs Audio and Transcript
5/9/2020
New COVID-19 Data Tracker Website for Laboratories
5/7/2020
Updated LOINC In Vitro Diagnostic (LIVD) Test Code Mapping for SARS-CoV-2 Test Results
5/6/2020
Lab Advisory: CDC Posts New Information about Serology Testing for COVID-19
CMS Issues Updated COVID-19 Frequently Asked Questions about Medicare Fee-for-Service Billing
5/5/2020
FDA Updates Policy about Serology Tests for COVID-19
5/4/2020
CDC Weekly Call with Clinical Labs Audio and Transcript
FDA Releases Revised Policy for COVID-19 Serology Testing
5/2/2020
CDC Releases Test Code Mapping Guide
5/1/2020
CMS Issues Additional Guidance on SARS-CoV-2 Laboratory Testing
4/28/2020
Trump Administration Releases COVID-19 “Testing Overview” and “Testing Blueprint”
4/27/2020
CDC Weekly Call with Clinical Labs Audio and Transcript
4/24/2020
NILA’s letter to CMS about reimbursement rates for antibody tests
4/22/2020
NILA Releases White Paper on Importance of Proficiency Testing for COVID-19
4/20/2020
CDC Weekly Call with Clinical Labs Audio and Transcript
AAB/NILA letter to FDA and CMS regarding COVID-19 testing
4/15/2020
CMS Increases Medicare Payments for COVID-19
4/13/2020
Lab Advisory: Updated Instructions for Use of CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel
CDC Weekly Call with Clinical Labs Audio and Transcript
4/10/2020
AAB/NILA Response Letter to Senators Duckworth, Durbin, and Markey, Regarding COVID-19
4/6/2020
CDC Weekly Call with Clinical Labs Audio and Transcript
4/1/2020
Laboratory Advisory: Updated Clinical Guidance on Testing Persons for Coronavirus Disease (COVID-19)
3/30/2020
CDC Weekly Call with Clinical Labs Audio and Transcript
Trump Administration Engages America’s Hospitals in Unprecedented Data Sharing
Trump Administration Provides Financial Relief for Medicare Providers
3/27/2020
The CARES Act Provides Temporary, but Not Immediate Relief to Clinical Laboratories
3/26/20
Senate Passes Stimulus Package with Relief for Clinical Laboratories
CMS Issues CLIA Guidance and FAQs for Laboratories During the COVID-19 Pandemic
3/24/2020
URGENT: NILA Members Call Your Senators Today
3/23/2020
CDC Weekly Call with Clinical Labs Audio and Transcript
3/21/2020
CDC Posts New Standard Operating Procedure for Creating Viral Transport Media
3/20/2020
NILA's COVID-19 Stimulus Request Letter to Capitol Hill
Supplies Needed for COVID-19 Testing
3/17/2020
Change to Result Interpretation for CDC EUA Assay
3/12/2020
COVID-19 Lab Letter to Vice President (PDF)
3/10/2020
CDC Updated Guidance on Testing Persons for Coronavirus Disease 2019 (COVID-19)
FDA releases FAQs on Diagnostic Testing for SARS-CoV-2 (COVID-19)
U.S. Department of Labor Offers Guidance For Preparing Workplaces for Coronavirus
3/9/2020
Coronavirus testing rollout marred by confusion and false starts (Yahoo! News)
3/5/2020
Lawmakers introduce legislation to expand nation’s diagnostic testing capabilities
3/2/2020
FDA Guidance to Develop Novel Molecular Diagnostic Tests for SARS-CoV-2
Laboratory Biosafety COVID-19 Frequently Asked Questions
2/27/2020
Criteria to Guide Evaluation of Person Under Investigation (PUI) for COVID-19
2/25/2020
Update: Public Health Response to the Coronavirus Disease 2019 Outbreak
2/24/2020
Public Health Response to the Coronavirus Disease 2019 Outbreak
2/21/2020
Frequently Asked Questions about Biosafety & COVID-19
2/18/2020 (from CRB)
Important FDA Notification Regarding Coronavirus
2/12/2020
CMS Update on Coronavirus Assay
2019
December 18, 2019
PAMA Lawsuit - ACLA's Reply in Support of Plaintiff’s Motion for Summary Judgment
December 17, 2019
LAB Act Passes the House
December 13, 2019
Senate Version (S. 3049) of the LAB Act Introduced
December 4, 2019
Over 30 Lab Organizations Sign Letter to Congress Supporting Passage of the LAB Act (H.R. 3584)
November 6, 2019
ALERT: FDA Issues Warning that Biotin may Interfere with Lab Tests, Especially Troponin
September 24, 2019
U.S. Dept. of Labor Issues Final Overtime Rule
September 16, 2019
Announcing NILA's 2020 Lab Leaders Forum and Mid-Winter Meeting
August 2, 2019
Update on ACLA's Successful Appeal in PAMA Lawsuit
July 30, 2019
ACLA's Appeal Upheld
July 19, 2019
LAB Act (HR 3584) Gains Traction: Act Now to Help
June 28, 2019
The Laboratory Access for Beneficiaries (LAB) Act
May 2, 2019
Clinical Diagnostic Laboratories: Resources about the Private Payor Rate-Based CLFS
April 18, 2019
MACs to Remind Labs to Collect and Report Private Payor Data
April 8, 2019
CLIA Proposes Updates to PT Regs
April 1, 2019
Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests Scheduled to Meeting July 22-23
April 1, 2019
CMS Schedules June 24 Public Meeting Regarding New and Reconsidered Clinical Diagnostic Lab Test Codes
March 26, 2019
Former NILA Member Remembered at Memorial Service
March 1, 2019
NILA Comments on CMS's Proposal to Increase CLIA Fees
January 7, 2019
Government Shutdown Delays Decision on Appeal of PAMA Lawsuit
January 2, 2019
HHS Releases Voluntary Cybersecurity Practices for the Healthcare Industry
2018
December 31, 2018
CMS Proposes 20% Increase to CLIA Fees
December 18, 2018
NILA Amends Statement Regarding GAO Report
December 17, 2018
GAO Report on Implementation of PAMA Fails to Base Recommendations on Facts
December 11, 2018
AAB Files Amicus Brief Supporting ACLA's PAMA Lawsuit Appeal
November 5, 2018
Changes to PAMA in the CY 2019 PFS Are Insufficient Says NILA
October 22, 2018
ACLA Files Notice of Appeal Regarding Denial of its Motion for Summary Judgement
September 24, 2018
Court Denies Motion for Summary Judgement In ACLA's PAMA Lawsuit
September 20, 2018
Office of Inspector General Posts Study of CLFS Payments in 2017
September 11, 2018
Curbing Drug Addiction and the Opioid Crisis, NILA White Paper, Press Release
September 10, 2018
AAB/NILA Comments to CMS Regarding Revisions to the Physician Fee Schedule for CY 2019
September 7, 2018
PAMA Laboratory Fee Schedule Cuts were Determined Using an Illegal Methodology Says NILA
August 7, 2018
36 Societies Forward Letter Asking Congress To Fix PAMA
August 7, 2018
NILA’s Key Informant Report About Impact of PAMA Cited in Forbes Op-Ed
July 13, 2018
CMS Releases Proposed Changes to the Physician Fee Schedule and Quality Payment Program
July 5, 2018
Laboratory Date of Service Exception
June 28, 2018
NILA Announces 2019 Lab Leaders Forum and Mid-Winter Meeting
May 2, 2018
NILA Report Reveals PAMA’s Adverse Impact on Community, Regional Labs, and Patient Access
April 4, 2018
CMS's Annual Laboratory Public Meeting to be held June 25, 2018, in Baltimore, Maryland
March 23, 2018
CMS Files Cross-Motion for Summary Judgment in PAMA Lawsuit
March 15, 2018
AAB and NILA Respond to RFI Issued by the House Ways and Means Committee Regarding the Opioid Crisis
March 9, 2018
NILA submits comments in response to CMS’ RFI regarding CLIA revisions
March 9, 2018
NILA and 12 Other Lab Groups Forward Letter to CMS Opposing Medicaid Fee Schedule Cuts
March 5, 2018
NILA Signs Addiction Policy Forum Letter
February 21, 2018
AAB/NILA Files Amicus Brief in PAMA Lawsuit
January 4, 2018
2018 Travel Allowance Rate Announced by CMS
January 2, 2018
Congressman Krishnamoorthi (D-IL) Asks CMS to Delay and Fix PAMA Regulations
2017
December 27, 2017
Seven Senate Finance Committee Members Express Concerns About PAMA’s CLFS Cuts for 2018
December 11, 2017
ACLA Files Lawsuit Challenging PAMA Rate Setting Method
November 18, 2017
Final 2018 CLFS Payment Rates Flawed
November 6, 2017
Eight Senators Sign Letter to CMS Secretary Verma Regarding PAMA
October 23, 2017
NILA/AAB Submit Comments on the 2018 Medicare Part B CLFS Proposed Rates
October 6, 2017
22 Organizations Sign Letter to CMS Administrator Seema Verma Urging Suspension of Proposed PAMA Cuts
September 22, 2017
NILA Issues Press Release on Proposed 2018 Medicare CLFS Rates
September 12, 2017
NILA Submits Comments Calling for Changes to PAMA Regulations
August 11, 2017
NILA Comments – Advisory Panel Meeting on Clinical Diagnostic Laboratory Tests
July 21, 2017
CMS Issues Agenda, Code List for July 31 CLFS Public Meeting
July 17, 2017
CMS Requests Feedback from Labs as Part of Physician Fee Schedule Rule
March 30, 2017
Deadline for Reporting PAMA Private Payor Data Extended to May 30, 2017
March 24, 2017
NILA Leads Lab Groups in Calling for Delay and Fix of PAMA
February 27, 2017
New Professional and General Liability Insurance
January 13, 2017
FDA Releases Discussion Paper on Oversight of LDTs
January 10, 2017
CMS Releases Guidance for Submitting Private Payor Data as Required by PAMA
2016
December 15, 2016
NILA Press Release: NILA Applauds House Freedom Caucus Recommendation on Immediate Repeal of Medicare Lab Payment Reform Rule
November 23, 2016
Final Determinations for Repricing Definitive Drug Tests
November 23, 2016
FDA Drops Guidances for LDTS
November 9, 2016
NILA Press Release: Eighty-Eight Members of Congress Sign Bipartisan Letter to HHS Requesting Delay of PAMA
November 7, 2016
Final Bipartisan Sign-On Letter Regarding PAMA Implementation
October 5, 2016
OIG Releases Reports on Medicare Payments for Lab Tests in 2015; Update on CMS’s Progress on Changing How Medicare Pays for Lab Tests
September 12, 2016
NILA Comments on Hospital Outpatient Prospective Payment System (HOPPS)
August 24, 2016
CMS Releases HCPCS Codes to be Reported Under PAMA
August 18, 2016
PAMA Advisory Panel to Meet September 12, 2016
August 17, 2016
FDA Releases Guidance: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatitis B Virus
August 9, 2016
NILA Comments to Support Reconsideration for Final Payment Determinations for Toxicology Codes G0840, G0481, G0482, G0483
August 4, 2016
Medicare Advisory Panel Votes in Favor of NILA's Reconsideration Requests for Toxicology Codes G0480, G0481, G0482, G0483
July 7, 2016
FDA Releases Draft Guidances for Next Generation Sequencing-based Tests
July 6, 2016
HHS announces new actions to combat opioid epidemic
June 30, 2016
NILA Requests CMS to Allow Reconsideration of Tier 1 Codes (G0480)
June 23, 2016
Final PAMA Regulations Published in Federal Register
June 18, 2016
NILA Comments on PAMA Regulations
June 17, 2016
Final PAMA Regulations Released
June 3, 2016
Announcement of the Advisory Panel on Clinical Diagnostic Laboratory Tests Meeting on July 18, 2016
April 14, 2016
NILA Requests Meeting With CMS to Discuss PAMA Regulations
March 28, 2016
Authorization of Emergency Use: In Vitro Diagnostic Device for Diagnosis of Zika Virus Infection
March 17, 2016
May 2, 2016, Workshop on LC/MS-Based Devices
March 3, 2016
Emergency Use of In Vitro Diagnostic Tests for Detection of Zika Virus and/or Diagnosis of Zika Virus
February 1, 2016
AAB's Resource Center for Zika Virus
January 18, 2016
NILA Files Reconsideration Request for CMS’s Drug Coding/Payment Policy
January 7, 2016
Senators Hatch (R-UT) and Wyden (D-OR) Urge CMS to Delay PAMA Reporting System
2015
December 17, 2015
44 U.S. Representatives Sign Letter Regarding CMS’s Proposed PAMA Regulations
December 15, 2015
19 Senators Sign Letter Regarding CMS’s Proposed PAMA Regulations
December 7, 2015
NILA Comments on LCD “MolDX: Biomarkers in Cardiovascular Risk Assessment”
November 24, 2015
NILA Comments on CLFS Proposed Payment System (PAMA Regs)
November 24, 2015
New York Bill Vetoed Requiring NY Personnel Laws to be Applied Nationwide
November 24, 2015
11/10/15 MLN Connects National Provider Call on Clinical Diagnostic Lab Test Payment System Proposed Rule (Transcript)
November 23, 2015
NILA Comments on New CMS Payments for Drug Tests
November 18, 2015
CMS Issues Final Coding / Pricing For Drug Test Codes in CY 2016
November 17, 2015
The Public Health Evidence for FDA Oversight of Laboratory Developed Tests: 20 Case Studies
October 26, 2015
NILA Comments On 2016 Clinical Laboratory Fee Schedule (CLFS) Coding and Pricing Determination For Toxicology Testing.
October 26, 2015
NILA and 7 Other Health Care Organizations Forward Letter To Senate and House Regarding CLIA Modernization and Oversight of LDTs
October 8, 2015
CMS Announces PAMA Advisory Panel Meeting on October 19, 2015
September 29, 2015
NILA Press Release on Proposed PAMA Regulations
September 28, 2015
California Assembly Bill No. 940
?September 25, 2015
?CY 2016 Clinical Laboratory Fee Schedule Determinations
September 25, 2015
Proposed PAMA Regulations Released
September 10, 2015
New Medicare Policy for CV Risk Assessment Panels
August 28, 2015
Laboratory-developed tests are not the practices of medicine (article via MLO)
August 7, 2015
CMS Announces PAMA Advisory Panel on Clinical Lab Tests
June 17, 2015
CMS Public Meeting on CY 2015 Updates to the Part B Clinical Laboratory Fee Schedule (CFLS)
June 1, 2015
CCLA Lawsuit Regarding Local Coverage Determinations Dismissed (via Pathology Blawg)
May 22, 2015
Palmetto GBA Policy on Next Generation Sequencing (via Palmetto GBA)
February 23, 2015
AAB and NILA Release Comments on HELP Committee Report
February 4, 2015
AAB and NILA Release Comments on FDA's Draft Guidances on LDTs
NILA Comments on 21st Century Cures Diagnostic Tests Initiative
2014
November 3, 2014
Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems
November 3, 2014
CMS Publishes Physician Fee Schedule Final Rule
September 8, 2014
NILA Comments on 2015 Medicare Physician Fee Schedule Proposed Rule
July 11, 2014
Summary of Calendar Year 2015 Physician Fee Schedule (PFS) Proposed Rule
July 11, 2014
OIG Report on Laboratory Billing Provides More Questions Than Answers
June 25, 2014
Special Fraud Alert: Laboratory Payments to Referring Physicians